Accredited Investors Inc. Purchases Shares of 11,826 Sientra, Inc. (SIEN)

Accredited Investors Inc. purchased a new stake in shares of Sientra, Inc. (NASDAQ:SIEN) during the second quarter, Holdings Channel reports. The fund purchased 11,826 shares of the medical instruments supplier’s stock, valued at approximately $115,000.

Other institutional investors have also modified their holdings of the company. KCG Holdings Inc. acquired a new position in shares of Sientra during the first quarter valued at approximately $147,000. Renaissance Technologies LLC acquired a new position in shares of Sientra during the first quarter valued at approximately $224,000. Morgan Stanley boosted its position in shares of Sientra by 449.6% in the first quarter. Morgan Stanley now owns 128,358 shares of the medical instruments supplier’s stock valued at $1,081,000 after buying an additional 105,005 shares in the last quarter. Cannell Capital LLC boosted its position in shares of Sientra by 2.3% in the first quarter. Cannell Capital LLC now owns 1,139,571 shares of the medical instruments supplier’s stock valued at $9,595,000 after buying an additional 26,000 shares in the last quarter. Finally, Mission Wealth Management LLC acquired a new position in shares of Sientra during the first quarter valued at approximately $104,000. 77.80% of the stock is owned by institutional investors.

Shares of Sientra, Inc. (NASDAQ:SIEN) opened at 10.22 on Friday. Sientra, Inc. has a 52-week low of $6.92 and a 52-week high of $11.47. The stock’s 50 day moving average is $10.45 and its 200 day moving average is $8.95. The stock’s market capitalization is $195.53 million.

Sientra (NASDAQ:SIEN) last released its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported ($0.55) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.59) by $0.04. The business had revenue of $8.20 million during the quarter, compared to analyst estimates of $6.97 million. Sientra had a negative net margin of 173.83% and a negative return on equity of 52.30%. Sientra’s revenue was up 32.3% on a year-over-year basis. Equities research analysts expect that Sientra, Inc. will post ($2.31) earnings per share for the current fiscal year.

WARNING: “Accredited Investors Inc. Purchases Shares of 11,826 Sientra, Inc. (SIEN)” was first posted by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://transcriptdaily.com/2017/08/13/accredited-investors-inc-purchases-shares-of-11826-sientra-inc-sien.html.

Several brokerages have commented on SIEN. Lake Street Capital reissued a “buy” rating and issued a $15.00 price target (up previously from $11.00) on shares of Sientra in a research report on Tuesday, August 8th. Zacks Investment Research raised shares of Sientra from a “sell” rating to a “hold” rating in a research report on Wednesday, July 12th. Stephens started coverage on shares of Sientra in a research report on Tuesday, July 11th. They set an “overweight” rating and a $12.00 price objective for the company. Finally, ValuEngine raised shares of Sientra from a “sell” rating to a “hold” rating in a research report on Thursday, June 22nd.

About Sientra

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

Want to see what other hedge funds are holding SIEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sientra, Inc. (NASDAQ:SIEN).

Institutional Ownership by Quarter for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply